![3-(3,7-Dichloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine Hydrochloride](https://static.cymitquimica.com/products/86/img/MM0545.04-0025.png "Click to enlarge")
3-(3,7-Dichloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine Hydrochloride
CAS: 115189-28-1
Ref. 86-MM0545.04-0025
| 25mg | 811.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Product Information
Name:
3-(3,7-Dichloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine Hydrochloride
Controlled Product
Synonyms:
- Clomipramine Hydrochloride Imp. D (EP)
- Clomipramine Imp. D (EP)
- Clomipramine USP Related Compound D
- Clomipramine USP RC D
- Clomipramine Hydrochloride Imp. D (EP) as Hydrochloride
- 5H-Dibenz[b,f]azepine-5-propanamine
- 3,7-dichloro-10,11-dihydro-N,N-dimethyl-
- hydrochloride (1:1)
- 5H-Dibenz[b,f]azepine
- 3,7-dichloro-5-(3-dimethylaminopropyl)-10,11-dihydro-
- See more synonyms
- hydrochloride (6CI)
- Clomipramine Related Compound D as Hydrochloride
- Clomipramine Hydrochloride Impurity D as Hydrochloride
- Clomipramine Impurity D as Hydrochloride
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Mikromol
Long term storage:
Notes:
Chemical properties
Molecular weight:
385.76
Formula:
C19H22Cl2N2·ClH
Color/Form:
Neat
InChI:
InChI=1S/C19H22Cl2N2.ClH/c1-22(2)10-3-11-23-18-12-16(20)8-6-14(18)4-5-15-7-9-17(21)13-19(15)23, /h6-9,12-13H,3-5,10-11H2,1-2H3, 1H
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: 86-MM0545.04-0025 3-(3,7-Dichloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine Hydrochloride
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
